NL-OMON39373
Completed
Phase 4
A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation - Spartacus
niversitair Medisch Centrum Utrecht0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Heart and lung transplantation
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients \* 18 years;\* Patients admitted to the ICC of UMCU after heart or lung transplantation;\* Treated with tacrolimus (Prograft®; Astellas Pharma Europe);\* Informed consent obtained
Exclusion Criteria
- •\* Patients \< 18 years;\* Patients who die within one day after admission to the ICC of UMCU;\* Withdrawal of informed consent;\* Allergy towards tacrolimus or macrolides;\* Patients on total parenteral nutrition
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A Prospective, Multicenter, Open Label, Single Arm, Study to Assess the Safety & Performance of the Harmony Aortic Stimulation System (HASS) for the Treatment of Heart FailureCardiac FailureHeart Failure10019280NL-OMON51726van de Wetering CRC2
Completed
Phase 2
A randomized, open-label, parallel-group, multi-center study of adding edoxaban or clopidogrel to aspirin to maintain patency in subjects with peripheral arterial disease following femoropopliteal endovascular intervention-edoxaban in peripheral arterial disease (ePAD)narrowing of the peripheral arteries (mostly in the legs)periferal arterial disease10003216NL-OMON40071Daiichi Sankyo Development Ltd14
Completed
Phase 3
A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients with Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation.Schizofreniasplit personality10037173NL-OMON43400Janssen-Cilag6
Completed
Phase 4
A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual Antiplatelet Therapy (DAPT).NL-OMON52323BIOTRONIK AG1
Completed
Phase 2
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) [DELIVERS Study]NL-OMON47706Castle Creek Pharmaceuticals, LLC4